Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia.
Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia.
D. Martins‐de‐Souza,G. Maccarrone,6 Autores,C. Turck
2010 · DOI: 10.1016/j.jpsychires.2010.04.014
Journal of Psychiatric Research · 168 Citações
TLDR
The protein changes described here corroborate the importance of myelin/oligodendrocyte and energy metabolism in SCZ and highlight new potential biomarkers candidates that may contribute to the understanding of the pathogenesis of this complex disease.